|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/19 | |
| A61K 47/12 | |||
| A61K 47/26 | |||
| C07K 16/24 | |||
| A61K 39/395 |
| (11) | Number of the document | 2331078 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09791868.4 |
| Date of filing the European patent application | 2009-08-25 | |
| (97) | Date of publication of the European application | 2011-06-15 |
| (45) | Date of publication and mention of the grant of the patent | 2012-09-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/054842 |
| Date | 2009-08-25 |
| (87) | Number | WO 2010/027766 |
| Date | 2010-03-11 |
| (30) | Number | Date | Country code |
| 92326 P | 2008-08-27 | US |
| (72) |
LI, Xuhong, US
KASHI, Ramesh, S., US
BADKAR, Aniket, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | LYOPHILIZED FORMULATIONS OF ENGINEERED ANTI-IL-23P19 ANTIBODIES |
| LYOPHILIZED FORMULATIONS OF ENGINEERED ANTI-IL-23P19 ANTIBODIES |